Target
Apolipoprotein L1
Ligand
BDBM615180
Substrate
n/a
Meas. Tech.
Acute APOL1 Thallium Assay
IC50
600±n/a nM
Citation
 CAO, JCOME, JHDAKIN, LADENIS, FDORSCH, WAFORTIER, AHAMEL, MKRUEGER, EBLEDFORD, BNANTHAKUMAR, SSNICOLAS, OSAYEGH, CSENTER, TJWANG, TBRODNEY, MHU, KROSE, PGAGNON, KSHI, YSHRESTHA, MMEDEK, AWITKOS, F INHIBITORS OF APOL1 AND METHODS OF USING SAME US Patent  US20230271945 Publication Date 8/31/2023
Target
Name:
Apolipoprotein L1
Synonyms:
APOL | APOL1 | APOL1_HUMAN | Apo-L | ApoL-I | Apolipoprotein L | Apolipoprotein L-I | Apolipoprotein L1
Type:
PROTEIN
Mol. Mass.:
43969.63
Organism:
Homo sapiens
Description:
ChEMBL_120089
Residue:
398
Sequence:
MEGAALLRVSVLCIWMSALFLGVGVRAEEAGARVQQNVPSGTDTGDPQSKPLGDWAAGTMDPESSIFIEDAIKYFKEKVSTQNLLLLLTDNEAWNGFVAAAELPRNEADELRKALDNLARQMIMKDKNWHDKGQQYRNWFLKEFPRLKSELEDNIRRLRALADGVQKVHKGTTIANVVSGSLSISSGILTLVGMGLAPFTEGGSLVLLEPGMELGITAALTGITSSTMDYGKKWWTQAQAHDLVIKSLDKLKEVREFLGENISNFLSLAGNTYQLTRGIGKDIRALRRARANLQSVPHASASRPRVTEPISAESGEQVERVNEPSILEMSRGVKLTDVAPVSFFLVLDVVYLVYESKHLHEGAKSETAEELKKVAQELEEKLNILNNNYKILQADQEL
  
Inhibitor
Name:
BDBM615180
Synonyms:
3-(5,6-difluoro-7-methyl-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide (99) | US20230271945, Compound 99
Type:
Small organic molecule
Emp. Form.:
C22H21F2N3O3
Mol. Mass.:
413.4172
SMILES:
Cc1c(F)c(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: